Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNano Genomics Inc (DE:2Y3)
BERLIN:2Y3
BioNano Genomics (2Y3) Stock Price & Analysis
0 Followers
2Y3 Stock Chart & Stats
Day’s Range€4.39 - €5.31
52-Week Range― - ―
Previous Close€4.39
Volume0.00
Average Volume (3M)N/A
Market Cap
$112.49M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Aug 09, 2023EPS Estimate
-€0.98Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.63Price Target Upside-40.03% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering4
BioNano Genomics News
2Y3 FAQ
What was BioNano Genomics Inc’s price range in the past 12 months?
Currently, no data Available
What is BioNano Genomics Inc’s market cap?
Currently, no data Available
When is BioNano Genomics Inc’s upcoming earnings report date?
BioNano Genomics Inc’s upcoming earnings report date is Aug 09, 2023 which is 266 days ago.
How were BioNano Genomics Inc’s earnings last quarter?
BioNano Genomics Inc released its earnings results on May 09, 2023. The company reported -€1.095 earnings per share for the quarter, missing the consensus estimate of -€0.953 by -€0.141.
Is BioNano Genomics Inc overvalued?
According to Wall Street analysts BioNano Genomics Inc’s price is currently Overvalued.
Does BioNano Genomics Inc pay dividends?
BioNano Genomics Inc does not currently pay dividends.
What is BioNano Genomics Inc’s EPS estimate?
BioNano Genomics Inc’s EPS estimate is -€0.98.
How many shares outstanding does BioNano Genomics Inc have?
Currently, no data Available
What happened to BioNano Genomics Inc’s price movement after its last earnings report?
BioNano Genomics Inc reported an EPS of -€1.095 in its last earnings report, missing expectations of -€0.953. Following the earnings report the stock price went up 13.028%.
Which hedge fund is a major shareholder of BioNano Genomics Inc?
Among the largest hedge funds holding BioNano Genomics Inc’s share is Gilder Gagnon Howe & Co LLC.. It holds BioNano Genomics Inc’s shares valued at N/A.
---
BioNano Genomics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€2.63 (-40.03% Downside)
€2.63 (-40.03% Downside)
Blogger Sentiment
Bullish
DE:2Y3 Sentiment 83%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $92.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.23%
12-Months-Change
Fundamentals
Return on Equity
-51.51%
Trailing 12-Months
Asset Growth
-16.10%
Trailing 12-Months
Company Description
BioNano Genomics Inc
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
---
2Y3 Stock 12 Months Forecast
Average Price Target
€2.63
▼(-40.03% Downside)
Technical Analysis
Best Analysts Covering 2Y3
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-48.85%
assigned a buy rating 9 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -48.85% per trade.
---